Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[A case of lung adenocarcinoma with coexisting G719X and T790M EGFR mutations in which erlotinib was effective for the treatment of leptomeningeal carcinomatosis].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Mar 2013

Katono Ken, Kasajima Masashi, Ishihara Mikiko, Hayashi Nobuatsu, Nagashima Yujiro, Igawa Satoshi, Masuda Noriyuki

Abstract excerpt

A 68-year-old man was referred to our hospital because of an abnormal chest shadow. Adenocarcinoma was detected using percutaneous needle aspiration cytology from the left supraclavicular lymph node. The patient was diagnosed as having primary adenocarcinoma of the lung(cT1bN3M1b: BRA OSS). Exon 18G 719X and exon 20 T790M mutations of the EGFR gene were detected in the same specimen. For first-line chemotherapy,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to Brain Neoplasms

Share to Erlotinib Hydrochloride

Share to Meningeal Carcinomatosis

Share to Protein Kinase Inhibitors

Share to Quinazolines

Source

Identifiers

PMID: 23507602

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[A case of lung adenocarcinoma with coexisting G719X and T790M EGFR mutations in which erlotinib was effective for the treatment of leptomeningeal carcinomatosis].PMID 23507602Read ↗

[Assessing the usefulness of erlotinib in patients with unknown or negative epidermal growth factor receptor mutation status].Semantic proximity Read ↗

[A Case of Multiple Brain Metastases after Surgery for Lung Cancer Successfully Treated with Osimertinib].Semantic proximity Read ↗

Erlotinib combined with bevacizumab and chemotherapy in first line osimertinib-resistant NSCLC patient with leptomeningeal metastasis: A case report.Semantic proximity Read ↗

Great efficacy of bevacizumab plus erlotinib for leptomeningeal metastases from non-small cell lung cancer with initially positive EGFR mutation: a case report.Semantic proximity Read ↗

Erlotinib plus bevacizumab as an effective treatment for leptomeningeal metastases from EGFR mutation-positive non-small cell lung cancer.Semantic proximity Read ↗

Successful Remedy With Osimertinib in a Patient of Thr790Met-positive Non-small Cell Lung Cancer With Leptomeningeal Carcinomatosis and Resistant to GefitinibSemantic proximity Read ↗

Erlotinib versus gefitinib for control of leptomeningeal carcinomatosis in non-small-cell lung cancer.Semantic proximity Read ↗

Promising Effects of Afatinib on Leptomeningeal Carcinomatosis Derived from Erlotinib-resistant Lung Adenocarcinoma.Semantic proximity Read ↗

Long-term outcome after multidisciplinary approach for leptomeningeal carcinomatosis in a non-small cell lung cancer patient with poor performance status.Semantic proximity Read ↗

[A case of pulmonary pleomorphic carcinoma with epidermal growth factor receptor (EGFR) mutation].Semantic proximity Read ↗

[Response of Erlotinib in Lung Adenocarcinoma Harboring EGFR Sensitive Mutation in Cerebrospinal Fluid: Case Report].Semantic proximity Read ↗

Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.